Sort
48,018 grants matching “immunotherapy”
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
$639,130Heike Elizabeth Daldrup-Link · Stanford University · U24 · FY2023 · CA
MICRO/NANO-IMMUNOCHIP (UIC) DEVELOPMENT AND TESTING IN MICE AND HUMANS
$639,099Owen N Witte · California Institute Of Technology · U54 · FY2009 · CA
Targeting Intrinsic and Extrinsic Barriers to Treat Metastatic Pancreatic Cancer
$639,098Scott Andrew Gerber · University Of Rochester · R01 · FY2025 · CA
TUMOR IMMUNOTHERAPY WITH BIODEGRADABLE MICROSPHERES
$639,081Therapyx, Inc. · R44 · FY2004 · CA
A physical sciences approach to investigate the role of exosomes in metastatic progression
$639,040Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2024 · CA
NT-I7, a novel long-acting interleukin-7, in combination with anti-PD-1 checkpoint blockade for the treatment of glioablastoma
$639,004Jian Campian · Mayo Clinic Rochester · R01 · FY2025 · CA
A multimodal approach for immunotherapy of Staphylococcus aureus bacteremia
$638,953M. Javad Aman · Abvacc, Inc. · R01 · FY2025 · AI
A novel preclinical model of spontaneous metastasis
$638,924Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma
$638,806Arash Ash Alizadeh · Stanford University · U01 · FY2016 · CA
Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV Coinfection
$638,647Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R01 · FY2021 · AI
Development of Antibody and T-Cell Inducing Vaccines
$638,623Philip O. Livingston · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
$638,608Donald Ym Leung · National Jewish Health · U01 · FY2020 · AR
Immunization to Block the Effects of Nicotine
$638,585Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2009 · DA
Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma
$638,550Veronika Fedirko · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Alloreactive and autoreactive immune-mediated mechanisms of impaired epithelial regeneration in the GI tract
$638,529Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2019 · HL
Alloreactive and autoreactive immune-mediated mechanisms of impaired epithelial regeneration in the GI tract
$638,529Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2021 · HL
Alloreactive and autoreactive immune-mediated mechanisms of impaired epithelial regeneration in the GI tract
$638,529Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2020 · HL
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$638,498Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Antibody Engineering Program
$638,442Mitchell Ho · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Nano immunoconjugates to treat primary and metastatic HER2 positive breast cancer
$638,279Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2019 · CA
Engineered Vaccines for Neoantigen Targeted Cancer Immunotherapy
$638,247John Tanner Wilson · Vanderbilt University · R01 · FY2022 · CA
Engineering knotted peptide therapeutics for pediatric brain tumor patients
$638,218James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Project 2: Durable impact of HCV on innate and adaptive immunity
$638,169Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2024 · AI
A digital intervention to improve skin self-examination among melanoma survivors
$638,124Sharon L Manne · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Modulating the localization and persistence of microbial neoantigen vaccine vectors to enhance therapeutic efficacy
$638,120Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2025 · CA